Back to the newspaper
DEVELOPING · Attributed source report · science · World

Trial results posted: A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

NULLPEN · Source published 11/20/2026, 12:00:00 AM UTC

ClinicalTrials.gov records the first posting of results for study NCT04175613 on 2026-11-20. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

The source record

National Library of Medicine, National Institutes of Health

Source: ClinicalTrials.gov, National Library of Medicine, United States. Registry entries are filed by trial sponsors; the registry does not verify them.Retrieved 2026-11-20T17:20:24.992Z. Updated on NULLPEN 2026-11-20T17:20:29.647Z.Revision sha256:205cfa57a941754ceabe3c0731564eb6796a69f459d4adf90f209ce09ed45306